Research Core (Amnis ImageStreamX Core)
研究核心(Amnis ImageStreamX 核心)
基本信息
- 批准号:8444012
- 负责人:
- 金额:$ 9.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-08-17 至
- 项目状态:未结题
- 来源:
- 关键词:Autoimmune DiseasesAutoimmunityCell CommunicationCellsCessation of lifeConfocal MicroscopyDNA Sequence RearrangementDataData AnalysesData SetDiseaseDisease PathwayEtiologyEventFlow CytometryGrantImageImageryImmune System DiseasesLearningMediatingMembrane ProteinsMethodsMicroscopyMindModelingPathogenesisPhaseResearchResearch PersonnelRheumatismRunningSample SizeSamplingSignal TransductionSiteTechnologyTimeTrainingWorkbasecell typedisabilityexperienceinstrumentmedical schoolsranpirnaseresearch studyresponsesuccesstool
项目摘要
We propose to establish a new Amnis ImageStreamX Core. Microscopy can image cytological rearrangements, cell:cell interactions, protein and membrane localization, and cell signaling events. However, such methods are neither high throughput nor quantitative. Nor are they adapted for real-time signaling or facile for the separation of defined cell types from mixtures. With these limitations in mind, Yale School of Medicine (YSM) acquired through a shared instrument grant an Amnis ImageStreamX. The Amnis ImageStreamX is a multispectral imaging instrument that acquires 12 channels of cellular imagery. By collecting large numbers of images per sample and providing numerical representation of image-based features, the ImageStreamX combines the per cell information content of standard microscopy with the statistical significance afforded by large sample sizes in standard flow cytometry. The best applications for the ImageStreamX take advantage of its abilities to locate and quantitate the distribution of signals on, within or between cells. This is the only such instrument at YSM. While there have been important discoveries made with the Amnis, the instrument is clearly underutilized. This is despite an enthusiastic initial response during a trial period wherein an expert from Amnis assisted in planning experiments, running samples and analyzing data on-site for 3 days. During this short time, preliminary data were obtained for 10 projects from 10 independent investigators. Whereas this early success was achieved with an expert on-site operator, the model applied for ongoing use of the Amnis was to treat as a user-operated 4-colorfiow cytometer. This model was not self-sustaining. Key aspects of the technology and in particular the required analysis of massive data sets rendered optimal use of the Amnis more complicated than a flow cytometer and therefore less accessible. This proposal seeks to remedy this by applying lessons learned by the P30 2P Core for which a dedicated and experienced operator participates in all phases of the work including experimental planning, training of users, imaging, assistance and training in data analysis. We propose to apply the same model to the Amnis so as to augment its impact on the study of rheumatic and immunological diseases, and the pathways that mediate their pathogenesis.
我们建议建立一个新的Amnis Imagestreamx核心。显微镜可以图像细胞学重排,细胞:细胞相互作用,蛋白质和膜定位以及细胞信号传导事件。但是,这种方法既不是高吞吐量也不是定量的。它们也不适用于实时信号传导或便利,以将定义的细胞类型从混合物中分离出来。考虑到这些局限性,耶鲁大学医学院(YSM)通过共享的仪器授予Amnis Imagestreamx获得。 Amnis ImagestreamX是一种多光谱成像仪器,可获得12个细胞成像通道。通过收集每个样品的大量图像并提供基于图像的特征的数值表示,ImageStreamx结合了标准显微镜的每个细胞信息含量与标准流式细胞仪中大样本量提供的统计显着性。 Imagestreamx的最佳应用利用了其能力定位和定量单元内或之间的信号分布。这是YSM唯一的仪器。虽然羊膜有重要的发现,但该仪器显然未被充分利用。尽管在试验期间有热情的初步响应,但AMNIS的专家协助计划实验,运行样品并在现场分析数据3天。在此短时间内,从10位独立研究人员那里获得了10个项目的初步数据。尽管这一早期成功是通过专家现场运营商实现的,但该模型旨在持续使用AMNIS作为用户操作的4-Colorfiow细胞图仪。这个模型不是自我维持的。技术的关键方面,尤其是对大规模数据集的所需分析,使AMNIS的最佳使用比流式细胞仪更为复杂,因此易于访问。该建议旨在通过应用P30 2P核心所学的教训来解决此问题,专门的经验丰富的操作员参与了工作的各个阶段,包括实验计划,培训用户,成像,帮助和数据分析中的培训。我们建议将相同的模型应用于AMNIS,以增强其对风湿性和免疫疾病研究的影响,以及介导其发病机理的途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Warren D Shlomchik其他文献
Pilot Trial of IFN-γ and Donor Lymphocyte Infusion to Treat Relapsed AML and MDS after Allogeneic Hematopoietic Stem Cell Transplantation
- DOI:
10.1182/blood-2022-157054 - 发表时间:
2022-11-15 - 期刊:
- 影响因子:
- 作者:
Sawa Ito;Elizabeth F Krakow;Kedwin Ventura;Amy Rodger;Emily Geramita;Erika Moore;Geoffrey R Hill;Warren D Shlomchik - 通讯作者:
Warren D Shlomchik
A Phase 1/1b Multicenter Ascending Dose Study to Evaluate the Safety of HA-1 Minor Histocompatibility Antigen-Reactive TCR-Modified T Cells (BSB-1001) in Patients Undergoing HLA-Matched Allogenic Hematopoietic Stem Cell Transplant (alloSCT) for MRD<sup>+</sup> AML or ALL or Poor/Very Poor Risk MDS
- DOI:
10.1182/blood-2022-168949 - 发表时间:
2022-11-15 - 期刊:
- 影响因子:
- 作者:
Sawa Ito;Christine Voigt;Constantinos Panousis;Tim Mayall;Mark Shlomchik;Jennifer Roy;Egidio Brocca Cofano;Stephanie Stras;David Apelian;Warren D Shlomchik - 通讯作者:
Warren D Shlomchik
Warren D Shlomchik的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Warren D Shlomchik', 18)}}的其他基金
Mechanisms whereby IFN-gamma sensitizes AML to the graft-vs-leukemia effect
IFN-γ 使 AML 对移植物抗白血病效应敏感的机制
- 批准号:
10394937 - 财政年份:2021
- 资助金额:
$ 9.97万 - 项目类别:
Mechanisms whereby IFN-gamma sensitizes AML to the graft-vs-leukemia effect
IFN-γ 使 AML 对移植物抗白血病效应敏感的机制
- 批准号:
10609407 - 财政年份:2021
- 资助金额:
$ 9.97万 - 项目类别:
Mechanisms whereby IFN-gamma sensitizes AML to the graft-vs-leukemia effect
IFN-γ 使 AML 对移植物抗白血病效应敏感的机制
- 批准号:
10217590 - 财政年份:2021
- 资助金额:
$ 9.97万 - 项目类别:
Graft-versus-Host Disease: Local Maintenance in Target Tissues by Tissue Resident Memory-Type Cells.
移植物抗宿主病:组织驻留记忆型细胞对目标组织的局部维持。
- 批准号:
9756456 - 财政年份:2018
- 资助金额:
$ 9.97万 - 项目类别:
Graft-versus-Host Disease: Local Maintenance in Target Tissues by Tissue Resident Memory-Type Cells.
移植物抗宿主病:组织驻留记忆型细胞对目标组织的局部维持。
- 批准号:
10165801 - 财政年份:2018
- 资助金额:
$ 9.97万 - 项目类别:
GVL Resistance: Immune selection, T cell ignorance and T cell exhaustion
GVL 抵抗:免疫选择、T 细胞无知和 T 细胞耗竭
- 批准号:
8675278 - 财政年份:2013
- 资助金额:
$ 9.97万 - 项目类别:
GVL Resistance: Immune selection, T cell ignorance and T cell exhaustion
GVL 抵抗:免疫选择、T 细胞无知和 T 细胞耗竭
- 批准号:
8477401 - 财政年份:2013
- 资助金额:
$ 9.97万 - 项目类别:
GVL Resistance: Immune selection, T cell ignorance and T cell exhaustion
GVL 抵抗:免疫选择、T 细胞无知和 T 细胞耗竭
- 批准号:
9039753 - 财政年份:2013
- 资助金额:
$ 9.97万 - 项目类别:
Dendritic Cell Subsets and Paths of Maturation in GVHD
GVHD 中的树突状细胞亚群和成熟途径
- 批准号:
8117703 - 财政年份:2010
- 资助金额:
$ 9.97万 - 项目类别:
Research Core (Amnis ImageStreamX Core)
研究核心(Amnis ImageStreamX 核心)
- 批准号:
8725465 - 财政年份:2007
- 资助金额:
$ 9.97万 - 项目类别:
相似国自然基金
超声驱动压电薄膜刺激迷走神经治疗自身免疫性心肌炎及机制研究
- 批准号:82302227
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
PEBP4通过下调TRAF6泛素化抑制自身免疫性慢性非细菌性前列腺炎的作用及机制研究
- 批准号:82360155
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
靶向T细胞的工程化间充质干细胞小细胞内囊泡治疗自身免疫性葡萄膜炎的研究
- 批准号:82371044
- 批准年份:2023
- 资助金额:46 万元
- 项目类别:面上项目
氨基酸感应器GCN2调控Beclin-1介导的自噬缓解自身免疫性甲状腺炎的作用研究
- 批准号:82370792
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
索拉非尼通过诱导调节性T细胞抑制自身免疫性疾病的研究
- 批准号:32370955
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Aire-dependent thymic B-1a cells play a key role in neonatal tolerance induction
Aire 依赖性胸腺 B-1a 细胞在新生儿耐受诱导中发挥关键作用
- 批准号:
10660882 - 财政年份:2023
- 资助金额:
$ 9.97万 - 项目类别:
Diversity supplement: Lymphatic regulation of lymph node function in lupus
多样性补充:狼疮淋巴结功能的淋巴调节
- 批准号:
10794867 - 财政年份:2023
- 资助金额:
$ 9.97万 - 项目类别:
Single-cell dissection of CD4 T cell changes in patients with immune-related adverse events following PD-1 inhibition
PD-1 抑制后出现免疫相关不良事件的患者 CD4 T 细胞变化的单细胞解剖
- 批准号:
10571532 - 财政年份:2023
- 资助金额:
$ 9.97万 - 项目类别: